There were three different immunostaining patterns observed for p16 immunoreactivity, that is, strong and diffuse cytoplasmic and nuclear overexpression, weak cytoplasmic and nuclear staining and no staining for all tumour cells. The gene discussed is CDKN2A; the disease is neoplasm.